These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 4202219)

  • 21. [Antibacterial properties of lincomycin in vitro and its chemotherapeutic activity].
    Shorin VA; Pevzner NS
    Antibiotiki; 1968 Sep; 13(9):810-5. PubMed ID: 4387685
    [No Abstract]   [Full Text] [Related]  

  • 22. Relative enzymatic hydrolysis rates of lincomycin esters. I. soluble esters.
    Taraszka MJ
    J Pharm Sci; 1971 Sep; 60(9):1414-7. PubMed ID: 5105893
    [No Abstract]   [Full Text] [Related]  

  • 23. [Studies on lincomycin, with special reference to intraperitoneal administration].
    Ishii Y; Ishibiki K; Oi H; Tsunekawa A; Nakamura Y
    J Antibiot B; 1967 Oct; 20(5):351-6. PubMed ID: 5300549
    [No Abstract]   [Full Text] [Related]  

  • 24. Penetration of antibiotics into the cerebrospinal fluid in inflammatory conditions. 2. Lincomycin.
    Vacek V; Hejzlar M; Skalova M
    Int Z Klin Pharmakol Ther Toxikol; 1968; 1(6):501-3. PubMed ID: 5718775
    [No Abstract]   [Full Text] [Related]  

  • 25. [Aspects of the therapeutic action of proteolytic enzymes and antibiotics in experimental staphylococcal infection. The effect of lincomycin, chymotrypsin and their combinations on leukocyte phagocytic activity].
    Berenshteĭn TF; Kardovich GA; Daniushchenkova NM
    Antibiotiki; 1978 Nov; 23(11):1002-5. PubMed ID: 718145
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis and SARs of novel lincomycin derivatives Part 5: optimization of lincomycin analogs exhibiting potent antibacterial activities by chemical modification at the 6- and 7-positions.
    Wakiyama Y; Kumura K; Umemura E; Masaki S; Ueda K; Sato Y; Hirai Y; Hayashi Y; Ajito K
    J Antibiot (Tokyo); 2018 Feb; 71(2):298-317. PubMed ID: 29089594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Microbiological, pharmacological and clinical principles of clindamycin therapy].
    Modde H
    Schweiz Med Wochenschr; 1971 Nov; 101(45):1632-3. PubMed ID: 4947153
    [No Abstract]   [Full Text] [Related]  

  • 28. Quantitative structure--activity relationships in leucomycin and lincomycin antibiotics.
    Martin YC; Lynn KR
    J Med Chem; 1971 Dec; 14(12):1162-6. PubMed ID: 5000561
    [No Abstract]   [Full Text] [Related]  

  • 29. [Effect of rifampicin, lincomycin and staphylococcal vaccine on the beta-lysin activity of the blood serum of animals infected with Staphylococcus].
    Balakliets NI; Tsyganenko AIa
    Antibiot Med Biotekhnol; 1987 Jan; 32(1):53-6. PubMed ID: 3566229
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Effect of lincomycin, chymotrypsin and their combinations on the splenic plasmacytic reaction and the antibody titer in experimental staphylococcal infection].
    Kardovich GA; Berenshteĭn TF; Daniushchenkova NM
    Antibiotiki; 1980 Aug; 25(8):606-9. PubMed ID: 7406472
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Action of lincomycin, chymotrypsin and their combinations on the course of experimental staphylococcal infection].
    Daniushchenkova NM; Kardovich GA; Berenshteĭn TF
    Antibiotiki; 1978 Apr; 23(4):330-3. PubMed ID: 646334
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 'Lincomycin' treatment of staphylococcal infection at high altitude.
    Ehrlich R; Mieszkuc BJ
    Nature; 1965 Sep; 207(5001):1109. PubMed ID: 5866317
    [No Abstract]   [Full Text] [Related]  

  • 33. Semisynthetic modification of antibiotic lincomycin.
    Sztaricskai F; Dinya Z; Puskás MM; Batta G; Masuma R; Omura S
    J Antibiot (Tokyo); 1996 Sep; 49(9):941-3. PubMed ID: 8931731
    [No Abstract]   [Full Text] [Related]  

  • 34. [Studies on the use of 7-chlor-7-desoxylincomycin in pediatrics].
    Daschner F; Marget W
    Arzneimittelforschung; 1969 Jun; 19(6):1003-6. PubMed ID: 5820027
    [No Abstract]   [Full Text] [Related]  

  • 35. Lincomycin in hospital practice.
    Duncan IB; Jeans B
    Can Med Assoc J; 1965 Sep; 93(13):685-91. PubMed ID: 5828940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The effect of erythromycin plus lincomycin association on renal staphylococcia in mice induced by "dissociated resistant" Staphylococcus aureus].
    Bourse R; Daver J; Monnier J
    Ann Inst Pasteur (Paris); 1969 Jun; 116(6):750-9. PubMed ID: 5363514
    [No Abstract]   [Full Text] [Related]  

  • 37. [Contribution to the rational treatment of staphylococcal osteomyelitis with lincomycin].
    Vacek V; Hejzlar M; Pavlanský R
    Cas Lek Cesk; 1968 Dec; 107(50):1505-14. PubMed ID: 5711202
    [No Abstract]   [Full Text] [Related]  

  • 38. Synthesis and bioactivity of lincomycin-2-phosphate.
    Morozowich W; Lamb DJ; Karnes HA; Mackellar FA; Lewis C; Stern KF; Rowe EL
    J Pharm Sci; 1969 Dec; 58(12):1485-9. PubMed ID: 5353265
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of lincomycin and staphylococcal vaccine on the course of experimental staphylococcal sepsis].
    Gabysehva LS; Tsyganenko AIa; Piten'ko NN
    Antibiot Khimioter; 1988 Oct; 33(10):779-81. PubMed ID: 3214214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recent developments in lincomycin research.
    Grady JE
    Int Z Klin Pharmakol Ther Toxikol; 1968; 1(6):533-8. PubMed ID: 4388454
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.